Allianz Asset Management Gmb H Iovance Biotherapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

$65.6 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $157,872 - $363,376	20,800 New	20,800 $308,000
Q2 2023 Aug 11, 2023	SELL	$5.36 - $9.06 $65,928 - $111,438	-12,300 Reduced 39.94%	18,500 $130,000
Q1 2023 May 11, 2023	BUY	$5.53 - $8.22 $170,324 - $253,176	30,800 New	30,800 $188,000
Q3 2022 Nov 08, 2022	SELL	$9.53 - $13.11 $459,155 - $631,639	-48,180 Reduced 60.32%	31,700 $304,000
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $168,304 - $483,545	26,380 Added 49.31%	79,880 $882,000
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $446,767 - $745,871	26,995 Added 101.85%	53,500 $1.03 Million
Q3 2021 Nov 10, 2021	SELL	$20.35 - $26.63 $588,522 - $770,139	-28,920 Reduced 52.18%	26,505 $654,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $169,685 - $343,630	-10,391 Reduced 15.79%	55,425 $1.44 Million
Q1 2021 May 13, 2021	SELL	$28.67 - $52.59 $2.13 Million - $3.92 Million	-74,464 Reduced 53.08%	65,816 $2.08 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $50,696 - $90,870	-1,808 Reduced 1.27%	140,280 $6.51 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $1.87 Million - $2.45 Million	-67,463 Reduced 32.19%	142,088 $4.68 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $1.15 Million - $1.74 Million	42,343 Added 25.32%	209,551 $5.75 Million
Q1 2020 May 14, 2020	SELL	$19.54 - $38.85 $827,929 - $1.65 Million	-42,371 Reduced 20.22%	167,208 $5.01 Million
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $1.4 Million - $2.3 Million	78,247 Added 59.58%	209,579 $5.8 Million
Q3 2019 Nov 13, 2019	SELL	$17.99 - $26.0 $2.92 Million - $4.21 Million	-162,071 Reduced 55.24%	131,332 $2.39 Million
Q2 2019 Aug 08, 2019	SELL	$9.78 - $24.52 $2.88 Million - $7.21 Million	-294,192 Reduced 50.07%	293,403 $7.19 Million
Q1 2019 May 13, 2019	BUY	$8.41 - $11.26 $855,053 - $1.14 Million	101,671 Added 20.92%	587,595 $5.59 Million
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $3.45 Million - $5.48 Million	-459,517 Reduced 48.6%	485,924 $4.3 Million
Q3 2018 Nov 13, 2018	BUY	$11.25 - $17.7 $2.67 Million - $4.2 Million	237,162 Added 33.48%	945,441 $10.6 Million
Q2 2018 Aug 13, 2018	BUY	$12.45 - $16.95 $6.6 Million - $8.99 Million	530,153 Added 297.63%	708,279 $9.07 Million
Q1 2018 May 14, 2018	SELL	$8.1 - $19.5 $104,076 - $250,555	-12,849 Reduced 6.73%	178,126 $3.01 Million
Q4 2017 Feb 13, 2018	SELL	$6.65 - $9.25 $22,922 - $31,884	-3,447 Reduced 1.77%	190,975 $1.53 Million
Q3 2017 Nov 13, 2017	SELL	$4.45 - $8.55 $1,842 - $3,539	-414 Reduced 0.21%	194,422 $1.51 Million
Q2 2017 Aug 14, 2017	BUY	N/A	194,836	194,836 $1.43 Million

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account